Labopharm Inc.'s (Nasdaq: DDSS) active pharmaceutical ingredient supplier resolved manufacturing deficiencies with the Food and Drug Administration sending the stock price soaring 50 cents to $1.86.
Labopharm's Supplier Resolves Issues With FDA
October 07, 2009 at 14:28 PM EDT
